Global markets have shown resilience, with U.S. indexes nearing record highs and smaller-cap indexes outperforming their larger counterparts, despite geopolitical tensions and economic uncertainties. In this context, identifying promising investment opportunities requires a keen eye for companies with solid fundamentals and growth potential. Penny stocks, though an outdated term, still represent smaller or newer companies that can offer significant value when backed by strong financials.
Name | Share Price | Market Cap | Financial Health Rating |
BP Plastics Holding Bhd (KLSE:BPPLAS) | MYR1.22 | MYR343.4M | ★★★★★★ |
DXN Holdings Bhd (KLSE:DXN) | MYR0.485 | MYR2.41B | ★★★★★★ |
ME Group International (LSE:MEGP) | £2.225 | £838.3M | ★★★★★★ |
LaserBond (ASX:LBL) | A$0.58 | A$68.57M | ★★★★★★ |
Lever Style (SEHK:1346) | HK$0.85 | HK$539.57M | ★★★★★★ |
Hil Industries Berhad (KLSE:HIL) | MYR0.885 | MYR293.77M | ★★★★★★ |
Next 15 Group (AIM:NFG) | £4.205 | £418.21M | ★★★★☆☆ |
Embark Early Education (ASX:EVO) | A$0.805 | A$146.79M | ★★★★☆☆ |
Secure Trust Bank (LSE:STB) | £3.59 | £68.47M | ★★★★☆☆ |
CSE Global (SGX:544) | SGD0.44 | SGD310.8M | ★★★★★☆ |
Click here to see the full list of 5,772 stocks from our Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Shandong Mining Machinery Group Co., Ltd. operates in the manufacturing and distribution of mining machinery and equipment, with a market cap of CN¥4.83 billion.
Operations: Revenue segments for the company are not reported.
Market Cap: CN¥4.83B
Shandong Mining Machinery Group, with a market cap of CN¥4.83 billion, faces challenges in its financial performance. Over the past year, earnings have declined significantly by 59.6%, and profit margins decreased to 3.3% from 6.7%. Despite high-quality earnings and more cash than debt, the company's return on equity is low at 2.4%. Short-term assets of CN¥3.3 billion comfortably cover both short- and long-term liabilities, but negative operating cash flow raises concerns about debt coverage sustainability. Recent reports show declining sales and net income compared to last year, highlighting ongoing financial pressures for this penny stock contender.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Fuan Pharmaceutical (Group) Co., Ltd. engages in the research, development, production, and sale of chemical drugs in China and has a market capitalization of approximately CN¥5.77 billion.
Operations: The company generates revenue of CN¥2.66 billion from its operations in the pharmaceutical industry.
Market Cap: CN¥5.77B
Fuan Pharmaceutical (Group) Co., Ltd., with a market cap of CN¥5.77 billion, shows mixed financial signals for investors exploring penny stocks. The company reported revenue of CN¥1.99 billion and net income of CN¥301.61 million for the first nine months of 2024, indicating profitability despite a decline in profit margins from 12.2% to 10.6%. Its seasoned management team and board provide stability, while short-term assets exceed liabilities significantly, suggesting sound liquidity management. However, negative earnings growth over the past year and low return on equity at 6.4% highlight areas needing improvement amidst stable weekly volatility and no significant shareholder dilution recently.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Tianjin Pengling Group Co., Ltd. specializes in the research, development, and manufacture of automotive fluid pipelines and sealing parts for both domestic and international markets, with a market cap of CN¥3.75 billion.
Operations: The company's revenue is primarily derived from its Non-Tire Rubber Products segment, which generated CN¥2.31 billion.
Market Cap: CN¥3.75B
Tianjin Pengling Group Ltd., with a market cap of CN¥3.75 billion, presents a complex picture for penny stock investors. The company's revenue from its Non-Tire Rubber Products segment reached CN¥2.31 billion, with recent earnings showing growth in sales and net income compared to the previous year. Despite this, challenges remain as profit margins have declined, and earnings have decreased by 8.2% annually over the past five years. Financial stability is evident as short-term assets cover liabilities well, but low return on equity at 2.7% and inexperienced management pose potential risks alongside stable weekly volatility and no significant shareholder dilution recently.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com